Trial reportZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026
[Clinical study on the efficacy of Wuling capsules combined with nucleos(t)ide analogues in the treatment of low-level viremia patients with chronic hepatitis B].
S X Zhao, W G Ren, M B Yang, X L Chi, H M Xiao, S P Ma, P Jia, Y M Nan
Abstract readRandomized Controlled TrialMulticenter StudyEnglish Abstract
In one paragraphTrial report in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
S X ZhaoDepartment of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China.
W G RenHebei Provincial Key Laboratory of Chronic Liver Disease and Liver Fibrosis, Hebei Provincial International Science and Technology Cooperation Base-International Joint Research Center for Molecular Diagnosis of Liver Cancer, Shijiazhuang 050051, China.
M B YangDepartment of Traditional Chinese Medicine Hepatology, Xi'an No. 8 Hospital, Xi'an 710061, China.
X L ChiDepartment of Hepatology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.
H M XiaoDepartment of Hepatology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China.
S P MaDepartment of Gastroenterology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China.
P JiaDepartment of Gastroenterology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China.
Y M NanDepartment of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Department of Gastroenterology, Hebei Medical University Third Hospital, Shijiazhuang 050051, China Hebei Provincial Key Laboratory of Chronic Liver Disease and Liver Fibrosis, Hebei Provincial International Science and Technology Cooperation Base-International Joint Research Center for Molecular Diagnosis of Liver Cancer, Shijiazhuang 050051, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antiviral AgentsDrugs, Chinese HerbalHepatitis B, ChronicNucleosidesViremiaAdultAlanine TransaminaseCapsulesDNA, ViralDrug Therapy, CombinationFemaleHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansMaleAlanine TransaminaseAntiviral AgentsCapsulesDNA, ViralDrugs, Chinese HerbalHepatitis B e AntigensHepatitis B Surface AntigensNucleosides
Identifiers
PMID42373438
PMCPMC13312285
What OpenQuestion holds
Textmetadata
Read underepoch 390